SCHEMBL20969699

SCHEMBL20969699

CCOc1ccc(CCN(Cc2ccc(C(=O)O)cc2)c2nc3cccc(F)c3s2)cc1OC

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KARS1 Q15046 1/20 0.53
TSHR P16473 1/20 0.42
ALDH1A1 P00352 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CALM1 P0DP23 1/20 0.39
ALOX5 P09917 1/20 0.39
LPAR1 Q92633 3/20 0.39
LPAR5 Q9H1C0 3/20 0.39
TAS2R14 Q9NYV8 1/20 0.38
MAPT P10636 1/20 0.38
APP P05067 1/20 0.37
PPARD Q03181 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20969613 0.94 KARS1 (0.55) KARS1ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL20969718 0.91 KARS1 (0.55) KARS1ALDH1A1MEN1KMT2AALOX5
SCHEMBL20969653 0.89 KARS1 (0.53) KARS1ALDH1A1MEN1KMT2AALOX5
SCHEMBL20969610 0.89 KARS1 (0.53) KARS1ALDH1A1MEN1KMT2AALOX5
SCHEMBL20969724 0.89 KARS1 (0.53) KARS1ALDH1A1MEN1KMT2AALOX5
SCHEMBL20969618 0.87 KARS1 (0.60) KARS1ALOX5LPAR1LPAR5PPARD
SCHEMBL20969598 0.86 KARS1 (0.51) KARS1ALDH1A1ALOX5LPAR1LPAR5
SCHEMBL20969601 0.86 KARS1 (0.59) KARS1ALDH1A1MEN1KMT2AALOX5
SCHEMBL20969682 0.85 KARS1 (0.70) KARS1ALOX5LPAR1LPAR5TAS2R14
SCHEMBL20969657 0.84 KARS1 (0.55) KARS1ALDH1A1ALOX5LPAR1LPAR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3483149-B1 BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME YUHAN CORP (KR) 2021-01-13 EP claimed
US-10383859-B2 Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same YUHAN CORPORATION (KR) 2019-08-20 US claimed
US-20190142809-A1 Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same YUHAN CORPORATION (KR) 2019-05-16 US claimed
EP-3483149-A1 BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME Yuhan Corporation (KR) 2019-05-15 EP claimed
EP-3483149-B1 BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME YUHAN CORP (KR) 2021-01-13 EP disclosed
US-10383859-B2 Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same YUHAN CORPORATION (KR) 2019-08-20 US disclosed
US-20190142809-A1 Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same YUHAN CORPORATION (KR) 2019-05-16 US disclosed
EP-3483149-A1 BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME Yuhan Corporation (KR) 2019-05-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190142809-A1 Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same ILK, SBDS, BDKRB1 KARS1 6/4885TSHR 991/4885ALDH1A1 3073/4885
US-10383859-B2 Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same ILK, SBDS, BDKRB1 KARS1 6/4885TSHR 991/4885ALDH1A1 3073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.